Maxim Group Rates Braiin (BRAI) buy, $10 Price Target
Maxim Group maintained its buy rating for Braiin Limited with a $10 target, a 5.48% downside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
Maxim Group rated Braiin Limited ($BRAI) "buy" with a $10 price target on June 15, 2026.
Since the rating, $BRAI is up 2.9% after 1 week, down 23.0% after 1 month and down 40.7% to date (from the $7.35 close on Jun 15, 2026).
BRAI
Braiin Limited
Key Points
- Maxim Group reiterated a buy rating for Braiin Limited (BRAI) with a $10 price target on June 15, 2026.
- Maxim Group's $10 price target implies 5.48% downside from Braiin Limited's ($BRAI) current $10.58 share price.
- Braiin Limited, trading at $7.64, has a market cap of approximately $1.51 billion and operates in the technology sector.
- Morgan Stanley added 2,400 shares of Braiin Limited, while Royal Bank of Canada added 495 shares.
Get $BRAI trade alerts by text
We text you when insiders, Congress or big funds trade $BRAI. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Braiin Limited alert may contain errors. Disclosures
Maxim Group has reiterated its buy rating for Braiin Limited (NasdaqGM:BRAI) with a price target of $10. The announcement was made on June 15, 2026, by analyst Allen Klee. At the time of the report, Braiin Limited's shares were trading at $7.64.
Other Institutional Activity in Braiin Limited
Morgan Stanley grew its holdings by 2,400 shares, ending with 2,400 shares valued at about $16,704. Royal Bank of Canada added 495 shares, bringing its total to 495 shares worth approximately $3,000. Tower Research Capital LLC (TRC) also increased its stake by 3 shares, now holding 3 shares valued at $21.
Braiin Limited Stock Up 89.9%
Shares of Braiin Limited are trading near $7.64 on the NasdaqGM. The company has a market capitalization of approximately $1.51 billion. It operates with a 52-week low of $4.19 and a high of $33.00. The stock's 50-day moving average is $7.84, while the 200-day moving average is $7.75. Braiin Limited has a current ratio of 0.034 and a quick ratio of 0.026, indicating liquidity challenges.
$BRAI price target
Braiin Limited daily closes and this analyst's $10 target. Not advice.
Analysts Set New Price Targets
On June 15, 2026, Maxim Group initiated coverage with a buy rating and a $10 price target on Braiin Limited. This reflects the firm's positive outlook on the company's future performance.
About Braiin Limited
Braiin Limited is a technology company based in Subiaco, Western Australia. It focuses on enhancing farming productivity through the use of IoT, wireless connectivity, robotics, software, and AI/ML technologies. The company operates in Australia and New Zealand and employs five people. Braiin Limited was incorporated in 2022 and functions as a subsidiary of Northern Revival Acquisition Corporation.
Bottom Line
Maxim Group's reiteration of a buy rating for Braiin Limited suggests confidence in the company's potential. As a technology firm focused on agricultural solutions, Braiin Limited is navigating a challenging market with promising innovations. Investors should note that analyst ratings are forward-looking, while 13F filings and institutional activities are historical and may not reflect the current market conditions.
Related Filing Alerts
Source: Maxim Group's rating change on $BRAI (Jun 15, 2026). Written by software, not financial advice. How we make alerts